Microalbuminuria (Moderate Albumin Excretion) and its relationship with Silent myocardial ischemia in  treatment naïve type II diabetic patients

Abstract

Objective: To determine the frequency of microalbuminuria (MAU) or Moderate Albumin Excretion (MAE) in treatment naïve type II diabetic patients and to compare the frequency of silent myocardial ischemia in treatment naive Type-II diabetic patients with and without microalbuminuria.
 Methods: It was a cross sectional survey conducted in the outpatient Department, Jinnah Hospital Lahore, from 30th May 2015 to 29th November 2015. There were 227 patients, (consecutive treatment naïve type II diabetic patients), presenting to outpatient department were enrolled in the study. MAU/MAE, silent myocardial ischemia and effect modifiers like HbA1C > 7%, smoking pack years and dyslipidemia was determined. MAU/MAE was determined by urinary albumin excretion rate of 30-300 mg/24 hours and included patients underwent exercise tolerance test to diagnose silent myocardial ischemia.
 Results: Out of total 165 patients (72.7%) were male and remaining 62 patients (27.3%) were female. The 54 patients (23.8%) had MAU/MAE. The 44 patients (19.4%) had silent myocardial infarction. When we cross tabulated microalbuminuria with silent myocardial infarction, result were significant. Out of 54 patients with MAU/MAE, 16 cases had silent myocardial infarction.
 Conclusion: The frequency of microalbuminuria/ Moderate Albumin Excretion in treatment naïve type II diabetic patients was high and associated with the frequency of silent myocardial ischemia in treatment naïve type II diabetic patients with and without MAU MAU/MAE.
 doi: https://doi.org/10.12669/pjms.36.3.938
 How to cite this:Hussain Q, Bukhari MH, Afzaal F, Fatima W. Microalbuminuria (Moderate Albumin Excretion) and its relationship with Silent myocardial ischemia in treatment naïve type II diabetic patients. Pak J Med Sci. 2020;36(3):---------. doi: https://doi.org/10.12669/pjms.36.3.938
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Screening of Silent Myocardial Ischemia in Type 2 Diabetic Patients with Additional Atherogenic Risk Factors; The Applicability of Exercise Stress Test

“…These are peripheral vascular disease, family history of myocardial ischemia, smoking, hypertension, and hyperlipidemia. There are other risk factors revealed to be associated with SMI or CAD in some studies, were not considered, except for retinopathy and hyperglycemia (HbA1c), for example: microalbuminuria (11) , autonomic neuropathy ( 12) , and apolipoprotein (a) (13) . This study had showed an interesting finding, that is: as the number of the basic risk factors increases, the results of positive EST (which most likely suggests the occurrence of SMI) increases in type 2 diabetic patients.…”

Silent coronary artery disease in type 2 diabetes: a narrative review on epidemiology, risk factors, and clinical studies

“…The presence of diabetes target organ damage has been investigated in several studies, and a higher prevalence of silent CAD was demonstrated for retinopathy [20,26,55,93,94], neuropathy [11,[95][96][97][98][99][100], and nephropathy [59,[101][102][103][104], as well as for peripheral vascular disease [105][106][107][108][109][110][111][112].…”

“…Diabetic nephropathy, is a well-known, strong predictor of CVD, and its association with silent CAD has been highlighted in several studies, even in the early stages of chronic renal disease [59,[101][102][103][104]. Microalbuminuria, a marker of incipient nephropathy, has been shown to be significantly associated with silent CAD, and is a powerful predictor of the disease [60,[100][101][102][103]. Al-Humaidi et al [59] demonstrated that myocardial abnormalities detected by SPECT in T2DM, correlates with nephropathy.…”